# Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip

> **NCT00541489** · PHASE3 · COMPLETED · sponsor: **NicOx** · enrollment: 800 (estimated)

## Conditions studied

- Osteoarthritis
- Osteoarthritis, Hip

## Interventions

- **DRUG:** Naproxcinod
- **DRUG:** Naproxen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00541489
- **Lead sponsor:** NicOx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-09
- **Final completion:** —
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2009-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00541489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00541489, "Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00541489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*